200 related articles for article (PubMed ID: 26677895)
21. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of disintegrants functionality for orodispersible mini tablets.
Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
[TBL] [Abstract][Full Text] [Related]
25. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
26. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K
Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438
[TBL] [Abstract][Full Text] [Related]
27. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
Tan Q; Zhang L; Liu G; He D; Yin H; Wang H; Wu J; Liao H; Zhang J
Drug Dev Ind Pharm; 2013 Sep; 39(9):1364-71. PubMed ID: 22994163
[TBL] [Abstract][Full Text] [Related]
28. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
[TBL] [Abstract][Full Text] [Related]
29. New orodispersible mini-tablets for paediatric use - A comparison of isomalt with a mannitol based co-processed excipient.
Lura A; Luhn O; Suarez Gonzales J; Breitkreutz J
Int J Pharm; 2019 Dec; 572():118804. PubMed ID: 31678381
[TBL] [Abstract][Full Text] [Related]
30. Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone.
Mohammed KA; Ibrahim HK; Ghorab MM
Drug Deliv; 2016; 23(1):297-306. PubMed ID: 24833273
[TBL] [Abstract][Full Text] [Related]
31. In vitro determination of aceclofenac Mouth Dissolving Tablets.
Shobhit S; Gupta SK
Polim Med; 2013; 43(4):227-9. PubMed ID: 24596037
[TBL] [Abstract][Full Text] [Related]
32. Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.
Zhang Y; Li Z; Tang H; Ren W; Gao X; Sun Y; Zhao QX; Wang F; Liu J
Drug Dev Ind Pharm; 2020 Jan; 46(1):42-49. PubMed ID: 31794271
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
Sadeghi M; Hemmati S; Hamishehkar H
Drug Dev Ind Pharm; 2016; 42(5):769-75. PubMed ID: 26289005
[TBL] [Abstract][Full Text] [Related]
34. Effects of various excipients on tizanidine hydrochloride tablets prepared by direct compression.
Khan LG; Razvi N; Anjum F; Siddiqui SA; Ghayas S
Pak J Pharm Sci; 2014 Sep; 27(5):1249-54. PubMed ID: 25176379
[TBL] [Abstract][Full Text] [Related]
35. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
Chen YD; Liang ZY; Cen YY; Zhang H; Han MG; Tian YQ; Zhang J; Li SJ; Yang DS
Drug Des Devel Ther; 2015; 9():5815-25. PubMed ID: 26640367
[TBL] [Abstract][Full Text] [Related]
36. Preparation of Loratadine Orally Disintegrating Tablets by Semi-solid Extrusion 3D Printing.
Yi S; Xie J; Chen L; Xu F
Curr Drug Deliv; 2023; 20(6):818-829. PubMed ID: 36221886
[TBL] [Abstract][Full Text] [Related]
37. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
Moutasim MY; ElMeshad AN; El-Nabarawi MA
Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
[TBL] [Abstract][Full Text] [Related]
38. Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic.
Al-Khattawi A; Iyire A; Dennison T; Dahmash E; Bailey CJ; Smith J; Rue P; Mohammed AR
Curr Drug Deliv; 2014; 11(4):486-500. PubMed ID: 24655059
[TBL] [Abstract][Full Text] [Related]
39. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
Gowda V; Pabari RM; Kelly JG; Ramtoola Z
Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
[TBL] [Abstract][Full Text] [Related]
40. Polyols as filler-binders for disintegrating tablets prepared by direct compaction.
Bolhuis GK; Rexwinkel EG; Zuurman K
Drug Dev Ind Pharm; 2009 Jun; 35(6):671-7. PubMed ID: 19274511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
